Molbio Diagnostics Ltd (MOLBIO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Molbio Diagnostics Ltd reported sales of ₹408 Cr, operating profit of ₹101 Cr (OPM 25%) and net profit of ₹53 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
MOLBIO quarterly results (₹ Cr) Metric Jun 2025 Mar 2026 Jun 2026 Sales 100 561 408 Expenses 116 402 308 Operating Profit -16 159 101 OPM -16% 28% 25% Other Income 1 5 3 Interest 4 12 11 Depreciation 12 20 17 Profit before tax -31 132 76 Tax -23% 27% 31% Net Profit -24 96 53 EPS in Rs -10.51 8.06 5.21
MOLBIO profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Sales 837 1,020 1,446 Expenses 602 760 1,126 Operating Profit 234 260 320 OPM 28% 26% 22% Other Income -49 -4 9 Interest 14 18 33 Depreciation 41 45 64 Profit before tax 130 194 231 Tax 36% 29% 29% Net Profit 84 139 164 EPS in Rs 452.37 64.34 14.77 Dividend Payout 0% 0% 0%
MOLBIO balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Equity Capital 2 2 11 Reserves 821 966 1,158 Borrowings 184 147 450 Other Liabilities 211 346 496 Total Liabilities 1,218 1,461 2,115 Fixed Assets 289 290 536 CWIP 2 27 11 Investments 6 46 6 Other Assets 921 1,099 1,562 Total Assets 1,218 1,461 2,115
MOLBIO cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity - - 10 287 50 Cash from Investing Activity - - -45 -123 -54 Cash from Financing Activity - - -32 -26 276 Net Cash Flow - - -67 138 273 Free Cash Flow - - -7 232 1 CFO/OP - - 23% 141% 38%
MOLBIO ratios Metric Mar 2024 Mar 2025 Mar 2026 Debtor Days 186 97 103 Inventory Days 338 384 285 Days Payable 101 203 126 Cash Conversion Cycle 423 278 261 Working Capital Days 200 128 116 ROCE - 21% 18%